Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the ...

Patients who had positive ctDNA tests after surgery were almost twice as likely to be alive at 3 years if they received ...

Explore how cfDNA levels change around colorectal cancer surgery and their potential as non-invasive biomarkers for ...

A new research paper was published in Oncotarget’s Volume 16 on January 21, 2025, titled “Assessment of cfDNA release ...

Taken together, our results suggest that in addition to physiological age, comorbidities and unfavorable clinical traits, ...

A new research paper was published in Oncotarget's Volume 16 on January 21, 2025, titled "Assessment of cfDNA release dynamics during colorectal cancer surgery." Researchers from the University of ...

Xilio Therapeutics (XLO) announced initial data from its ongoing Phase 2 clinical trial evaluating vilastobart, or XTX101, a tumor-activated, ...

Supervised Exercise for Patients With Metastatic Breast Cancer: A Cost-Utility Analysis Alongside the PREFERABLE-EFFECT Randomized Controlled Trial Colorectal cancer (CRC) remains a major global ...